Provident Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.7M | Buy |
|
|||||
|
2025
Q1 | $75.8M | Buy |
|
|||||
|
2024
Q4 | $62.4M | Sell |
|
|||||
|
2024
Q3 | $72.3M | Sell |
|
|||||
|
2024
Q2 | $74.9M | Sell |
|
|||||
|
2024
Q1 | $66.9M | Sell |
|
|||||
|
2023
Q4 | $65.2M | Sell |
|
|||||
|
2023
Q3 | $56M | Sell |
|
|||||
|
2023
Q2 | $57.1M | Sell |
|
|||||
|
2023
Q1 | $51.4M | Buy |
|
|||||
|
2022
Q4 | $46.4M | Sell |
|
|||||
|
2022
Q3 | $46.9M | Sell |
|
|||||
|
2022
Q2 | $47.7M | Sell |
|
|||||
|
2022
Q1 | $48.9M | Buy |
|
|||||
|
2021
Q4 | $40.7M | Buy |
|
|||||
|
2021
Q3 | $33.3M | Buy |
|
|||||
|
2021
Q2 | $35.7M | Buy |
|